{"organizations": [], "uuid": "2fed2fdc6439a103b1e7ab4fccef6a0bce9d32b8", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-aviragen-and-vaxart-amend-terms-of/brief-aviragen-and-vaxart-amend-terms-of-merger-agreement-to-increase-the-value-for-aviragen-stockholders-idUSFWN1PX1DZ", "country": "US", "domain_rank": 408, "title": "BRIEF-Aviragen And Vaxart Amend Terms Of Merger Agreement To Increase The Value For Aviragen Stockholders", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-07T22:39:00.000+02:00", "replies_count": 0, "uuid": "2fed2fdc6439a103b1e7ab4fccef6a0bce9d32b8"}, "author": "", "url": "https://www.reuters.com/article/brief-aviragen-and-vaxart-amend-terms-of/brief-aviragen-and-vaxart-amend-terms-of-merger-agreement-to-increase-the-value-for-aviragen-stockholders-idUSFWN1PX1DZ", "ord_in_thread": 0, "title": "BRIEF-Aviragen And Vaxart Amend Terms Of Merger Agreement To Increase The Value For Aviragen Stockholders", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "value for aviragen stockholders", "sentiment": "negative"}, {"name": "aviragen board", "sentiment": "none"}, {"name": "aviragen therapeutics inc", "sentiment": "none"}, {"name": "viragen stockholders   aviragen therapeutics inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 7 (Reuters) - Aviragen Therapeutics Inc:\n* AVIRAGEN AND VAXART AMEND TERMS OF MERGER AGREEMENT TO INCREASE THE VALUE FOR AVIRAGEN STOCKHOLDERS\n* AVIRAGEN THERAPEUTICS INC - AVIRAGEN STOCKHOLDERS WOULD NOW OWN 49% OF COMBINED COMPANY, UP FROM 40% UNDER PREVIOUS AGREEMENT\n* AVIRAGEN THERAPEUTICS INC - AMENDED AGREEMENT HAS BEEN UNANIMOUSLY APPROVED BY BOARDS OF DIRECTORS OF BOTH COMPANIES\n* AVIRAGEN THERAPEUTICS INC - AVIRAGEN BOARD RECOMMENDS AVIRAGEN STOCKHOLDERS VOTE FOR MERGER AT SPECIAL MEETING OF STOCKHOLDERS ON FEBRUARY 9, 2018\n* AVIRAGEN THERAPEUTICS INC - ‍INTENDS TO RECONVENE SPECIAL MEETING OF STOCKHOLDERS TO VOTE ON PROPOSED MERGER ON FEB 9, 2018 AT 12:00 PM EST​ Source text for Eikon: Further company coverage:\n ", "external_links": [], "published": "2018-02-07T22:39:00.000+02:00", "crawled": "2018-02-07T23:03:57.000+02:00", "highlightTitle": ""}